INSIGHTS ON SOLID DOSE MANUFACTURING

• Safely Scaling High Potency API Manufacturing

  Scaling HPAPI production demands disciplined containment and exposure control. Integrated operating models help manage risk while enabling compliant, reliable scale‑up.

• Innovations In Orally Disintegrating Tablets For Pediatric Drug Delivery

  Delve into the evolving landscape of pediatric dosage forms, with a focus on how ODTs are emerging as a specialized and practical drug delivery system for children.

• Blister Solutions

  With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

• Navigating High-Potency OSD Manufacturing

  Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.

• Cytiva's Aseptic Filling Workcell User Group

  1/9/2026

  Discover how global collaboration among aseptic filling experts is driving innovation and improving operations.

• Optimizing DPI Production: Filling Technologies For Precision And Performance

  4/16/2025

  Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.

• Global Regulatory Harmonization: Comparisons In Aseptic Barrier Systems

  4/20/2026

  Compare global aseptic standards from the FDA, EMA, PIC/S, and WHO. Gain insights into how advanced barrier systems harmonize international requirements to ensure sterile product integrity and safety.

• Maximize Uptime And Yield With This Feeder Base Leveling System

  10/8/2025

  Learn how a patented leveling system provides real-time, three-gauge feedback, ensuring precision, maximizing uptime, and protecting your critical production equipment.

• Oral Delivery Of PROTACs: Integrating Molecular Design And Enabling Formulation

  8/20/2026

  Explore how integrated molecular design and formulation strategies can overcome the unique oral-delivery challenges of PROTACs, transforming complex degraders into viable, scalable medicines.